I'd love to see licensing as JDP has stated, however, I can't see it being appealing to pharma at the same time as financially beneficial to RAC.
One of the speculations I've thrown around to a few people is that RAC will organise a loan structure. If only there were someone with enough conviction, and deep enough pockets to loan a measly few mill to RAC....
RAC Price at posting:
95.5¢ Sentiment: None Disclosure: Held
